secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001437749-25-027247
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech posts August 2025 investor presentation; content not disclosed in filing
--------------------------------------------------------------------------------

- Filed 8-K on August 18, 2025, attaching investor presentation as Exhibit 99.1.
- Presentation dated August 2025; no specific financial or operational data extracted from the filing.
- No changes to previously disclosed guidance or material events evident from the filing alone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925027247/0001437749-25-027247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925027247/mbrx20250818_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-027247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer